2AY-46612-77840

4 vaccinations 14 coded responses 31 check-ins 14 free-text entries 1 call case

Sex: Female
Age at first dose: 56-60
ZIP prefix: 611 / IL
Registered: 2021-03-08

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-02-28
Dose 1 — Pfizer-BioNTech
2021-03-08
Registered in v-safe
2021-03-08
Health check-in — day 7, dose 1
Feeling: Fair · Fatigue or tiredness

Adult check-in
2021-03-14
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-03-21
Dose 2 — Pfizer-BioNTech
2021-03-21
Health check-in — day 0, dose 2
Feeling: Good · None

Adult check-in
2021-03-22
Survey response — days 1–6 daily, dose 2
MedDRA: Tinnitus — Feeling: Fair · Fever · Chills, Headache, Muscle or body aches, Nausea

Free text: Loud buzzing noise heard in both ears/inside head.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-23
Survey response — days 1–6 daily, dose 2
MedDRA: Disturbance in attention, Feeling hot — Feeling: Fair · Fever · Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Felt hot without fever, difficulty with concentration

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-24
Survey response — days 1–6 daily, dose 2
MedDRA: No adverse event — Feeling: Fair · Fatigue or tiredness

Free text: No

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-25
Survey response — days 1–6 daily, dose 2
MedDRA: Flatulence, Frequent bowel movements — Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Frequent bowel gas/movements but not diarrhea

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-27
Survey response — days 1–6 daily, dose 2
MedDRA: Depressed mood — Feeling: Fair · Headache

Free text: Sadness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-28
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-04-04
Survey response — day 14, dose 2
MedDRA: Condition aggravated, Erythema, Feeling hot, Headache, Inflammation, Nausea, Papule, Pre-existing disease, Skin discolouration — Feeling: Good · Be unable to work, Be unable to do your normal daily activities

Free text: A flare up of my autoimmune disease. S/Sxs: systemic inflammation, sense of internal heat w/o fever, moderate nausea & headache, skin color changes ranging deep red to violaceous, and reactivation of skin papules and and open sores.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-11
Health check-in — day 21, dose 2
Feeling: Fair

Adult check-in
2021-04-19
Survey response — day 28, dose 2
MedDRA: Headache — Feeling: Fair · Be unable to do your normal daily activities

Free text: Moderate to severe frontal headache in the late afternoon on 2 of 5 days.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-25
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-05-02
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-06-22
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-09-01
Dose 3 — Pfizer-BioNTech
2021-09-20
Survey response — 6 months, dose 2
MedDRA: Faeces soft, Flatulence — Feeling: Good · Be unable to do your normal daily activities

Free text: Frequent soft stools and increased gas.

MedDRA releases: 2024-11 · check-in free text available
2021-09-20
Survey response — day 14, dose 3
MedDRA: Faeces soft, Frequent bowel movements, Musculoskeletal stiffness, Myalgia — Feeling: Good · Be unable to do your normal daily activities

Free text: Increased frequency of very soft stools and increased body-wide muscle pain and stiffness.

MedDRA releases: 2024-11 · check-in free text available
2021-09-22
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2021-09-29
Survey response — day 28, dose 3
MedDRA: Arthralgia, Musculoskeletal stiffness, Myalgia, Pain — Feeling: Fair · Be unable to do your normal daily activities

Free text: Increase in body-wide joint pain on movement, and muscle pain and stiffness (mostly of the larger body muscle groups) with movement.

MedDRA releases: 2024-11 · check-in free text available
2021-10-06
Health check-in — day 35, dose 3
Feeling: Good

Adult check-in
2021-10-13
Health check-in — day 42, dose 3
Feeling: Fair

Adult check-in
2021-12-05
Survey response — 3 months, dose 3
MedDRA: Cystitis, Nephrolithiasis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Bladder infection and kidney stones- likely unrelated to Pfizer vaccinations. Have had NO s/sx commonly associated with a COVID-19 infection.

MedDRA releases: 2024-11 · check-in free text available
2022-03-03
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in
2022-05-03
Dose 4 — Pfizer-BioNTech
2022-05-14
Health check-in — day 7, dose 4
Feeling: Good · None

Adult check-in
2022-05-19
Health check-in — day 14, dose 4
Feeling: Good

Adult check-in
2022-05-24
Survey response — day 21, dose 4
MedDRA: Apathy, Depressed mood, Fatigue — Feeling: Fair · Be unable to do your normal daily activities

Free text: Depressed mood. Apathy. Tiredness.

MedDRA releases: 2024-11 · check-in free text available
2022-05-31
Survey response — day 28, dose 4
MedDRA: Apathy, Fatigue, Mental impairment — Feeling: Fair · Be unable to do your normal daily activities

Free text: Fatigue, mental dullness, apathy

MedDRA releases: 2024-11 · check-in free text available
2022-06-07
Health check-in — day 35, dose 4
Feeling: Fair

Adult check-in
2022-06-14
Health check-in — day 42, dose 4
Feeling: Good

Adult check-in
2022-08-02
Health check-in — 3 months, dose 4
Feeling: Good

Adult check-in
2022-11-01
Survey response — 6 months, dose 4
MedDRA: COVID-19, Malaise — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Contracted COVID-19 illness, took Paxlovid, and then experienced rebound symptoms two days after completing prescription.

MedDRA releases: 2024-11 · check-in free text available
2022-11-01
Report sent to call center — 6 months, dose 4
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-11-02
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-02-28	Pfizer-BioNTech
2	2021-03-21	Pfizer-BioNTech
3	2021-09-01	Pfizer-BioNTech	No
4	2022-05-03	Pfizer-BioNTech	No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 6 — days 1–6 daily, dose 2

2021-03-22

Systemic reaction (other): Loud buzzing noise heard in both ears/inside head.

2021-03-23

Systemic reaction (other): Felt hot without fever, difficulty with concentration

2021-03-24

Systemic reaction (other): No

2021-03-25

Systemic reaction (other): Frequent bowel gas/movements but not diarrhea

2021-03-27

Systemic reaction (other): Sadness

Release 6 — day 14, dose 2

2021-04-04

Symptoms: A flare up of my autoimmune disease. S/Sxs: systemic inflammation, sense of internal heat w/o fever, moderate nausea & headache, skin color changes ranging deep red to violaceous, and reactivation of skin papules and and open sores.

Release 7 — day 28, dose 2

2021-04-19

Symptoms: Moderate to severe frontal headache in the late afternoon on 2 of 5 days.

Release 9 — day 14, dose 3

2021-09-20

Symptoms: Increased frequency of very soft stools and increased body-wide muscle pain and stiffness.

Release 9 — 6 months, dose 2

2021-09-20

Symptoms: Frequent soft stools and increased gas.

Release 9 — day 28, dose 3

2021-09-29

Symptoms: Increase in body-wide joint pain on movement, and muscle pain and stiffness (mostly of the larger body muscle groups) with movement.

Release 10 — 3 months, dose 3

2021-12-05

Symptoms: Bladder infection and kidney stones- likely unrelated to Pfizer vaccinations. Have had NO s/sx commonly associated with a COVID-19 infection.

Release 11 — day 21, dose 4

2022-05-24

Symptoms: Depressed mood. Apathy. Tiredness.

Release 11 — day 28, dose 4

2022-05-31

Symptoms: Fatigue, mental dullness, apathy

Release 12 — 6 months, dose 4

2022-11-01

Symptoms: Contracted COVID-19 illness, took Paxlovid, and then experienced rebound symptoms two days after completing prescription.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Apathy	·	·	✓
SD	Arthralgia	·	·	✓
SD	Condition aggravated	✓	✓	✓
SD	COVID-19	·	·	✓
SD	Cystitis	·	·	✓
SD	Depressed mood	·	·	✓
SD	Erythema	✓	✓	✓
SD	Faeces soft	·	·	✓
SD	Fatigue	·	·	✓
SD	Feeling hot	✓	✓	✓
SD	Flatulence	·	·	✓
SD	Frequent bowel movements	·	·	✓
SD	Headache	✓	✓	✓
SD	Inflammation	✓	✓	✓
SD	Malaise	·	·	✓
SD	Mental impairment	·	·	✓
SD	Musculoskeletal stiffness	·	·	✓
SD	Myalgia	·	·	✓
SD	Nausea	✓	✓	✓
SD	Nephrolithiasis	·	·	✓
SD	Pain	·	·	✓
SD	Papule	○	✓	○
SD	Pre-existing disease	✓	✓	✓
SD	Skin discolouration	✓	✓	✓
SRO	Depressed mood	✓	✓	✓
SRO	Disturbance in attention	✓	✓	✓
SRO	Feeling hot	✓	✓	✓
SRO	Flatulence	✓	✓	✓
SRO	Frequent bowel movements	✓	✓	○
SRO	No adverse event	✓	✓	✓
SRO	Tinnitus	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release